Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study to Evaluate Impact of an Educational Programme About Diabetes, Comparing to Normal Clinical Practice, on Treatment Compliance and Disease Control of People With Type 2 Diabetes Followed in Primary Care Units in Portugal

NCT01728714 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01728714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01728714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study to Evaluate Impact of an Educational Programme About Diabetes, Comparing to Normal Clinical Practice, on Treatment Compliance and Disease Control of People With Type 2 Diabetes Followed in Primary Care Units in Portugal
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 19, 2014
Completion date
December 5, 2018
Enrollment
227 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type 2